Verrica Q2 FY26 net loss widens to $13.2 million; revenue drops 53.85% to $5.9 million
Reuters2026/08/06 20:35- Verrica posted Q2 2026 revenue of USD 5.9 million, down from USD 12.7 million a year earlier, while net loss widened to USD 13.2 million.
- U.S. YCANTH net product revenue rose 12.3% year over year to USD 5.1 million, driven by higher deliveries to distribution partners.
- License and collaboration revenue fell to USD 769,000 from USD 8.2 million, as the prior-year quarter included an USD 8 million one-time milestone.
- YCANTH dispensed applicator units climbed 28.3% from the prior quarter to 19,626, up 46.1% year over year.
- Topline data from the global Phase 3 common warts program is expected in mid-2027; a new USD 27.5 million credit facility could extend cash runway into 2028.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
EUR/USD Price Forecast: Holds key 100-day SMA at start of the US CPI week
Paying the price for supporting the yen? Japan's foreign reserves fell by $87.8 billions in August, possibly due to selling US Treasuries for funding.
Japanese authorities may have used part of their foreign exchange reserves, including foreign securities such as U.S. Treasury bonds, over the past month to fund record-sized foreign exchange intervention operations.

10-Yr Benchmark Govt Yields - Germany vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations